New hope for rare blood cancer: targeted drug zanubrutinib tested in chinese patients
NCT ID NCT07169331
First seen Sep 30, 2025 · Last updated May 21, 2026 · Updated 30 times
Summary
This study tests the drug zanubrutinib in 18 Chinese adults with Waldenström macroglobulinemia who have not yet received treatment. The goal is to see how well the drug controls the cancer and to check for side effects. Participants take the drug by mouth, and the study will measure tumor shrinkage and how long the response lasts.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WALDENSTRÖM'S MACROGLOBULINEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Hebei University
RECRUITINGBaoding, Hebei, 071000, China
-
Nanfang Hospital, Southern Medical University
RECRUITINGGuangzhou, Guangdong, 510515, China
-
Peking Union Medical College Hospital
RECRUITINGBeijing, Beijing Municipality, 100730, China
-
Sun Yat Sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, 510060, China
-
The First Affiliated Hospital, Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310003, China
-
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430022, China
-
Xiangya Hospital of Central South University
RECRUITINGChangsha, Hunan, 410008, China
-
Yichang Central Peoples Hospital
RECRUITINGYichang, Hubei, 443003, China
Conditions
Explore the condition pages connected to this study.